Premier said staffing constraints, geopolitical tension and pharmaceutical and device manufacturers stopping the production of widely used generic drugs to prioritize more profitable items has the hospital purchasing agents surveyed fearing supply chain issues to remain the same or get worse. VERADIGM EXTENDS FILING OF 2022 FINANCIALS TO SEPTEMBER: Veradigm said Wednesday that it has been granted another extension for from Nasdaq for filing its overdue form 10-K for the year ending Dec. 31, 2022, and its first quarter of 2023 for 10-Q until Sept. 18, 2023. Veradigm reiterated in a statement that it is still unable to file its 10-K and quarterly 10-Q because of an accounting error it blamed on software that will cause it to restate previously reported results for 2021 and 2022 with an expected reduction of revenue of about $40 million.